Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HSPB8 Facilitates the Oncogenesis and Advancement of Bladder Cancer via Activation of HSP27. | J Cancer | 2024 | 38213722 | PubTator, text mining | PubMed |
| Kinetic modeling of leucine-mediated signaling and protein metabolism in human skeletal muscle. | iScience | 2024 | 38188514 | PubTator, text mining | PubMed |
| Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response. | Mol Ther Nucleic Acids | 2024 | 38187140 | PubTator, text mining | PubMed |
| Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways. | Transl Oncol | 2024 | 38183801 | PubTator, text mining | PubMed |
| Inhibition of phosphatidylinositol 3-kinase catalytic subunit alpha by miR-203a-3p reduces hypertrophic scar formation via phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway. | Burns Trauma | 2024 | 38179473 | PubTator, text mining | PubMed |
| MAD2L2, a key regulator in ovarian cancer and promoting tumor progression. | Sci Rep | 2024 | 38167649 | PubTator, text mining | PubMed |
| The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer. | Biol Direct | 2024 | 38163864 | PubTator, text mining | PubMed |
| Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma. | Transl Oncol | 2024 | 38141377 | PubTator, text mining | PubMed |
| Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. | Noncoding RNA Res | 2024 | 38075202 | PubTator, text mining | PubMed |
| IDPpub: Illuminating the Dark Phosphoproteome Through PubMed Mining. | Mol Cell Proteomics | 2024 | 37993103 | PubTator, text mining | PubMed |
| PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression. | Oncogene | 2024 | 37875657 | PubTator, text mining | PubMed |
| Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer. | Genes Dis | 2024 | 37588202 | PubTator, text mining | PubMed |
| S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma. | Haematologica | 2024 | 37470139 | PubTator, text mining | PubMed |
| Cell death or survival: Insights into the role of mRNA translational control. | Semin Cell Dev Biol | 2024 | 37357122 | PubTator, text mining | PubMed |
| Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. | Mol Cell Biochem | 2024 | 37016182 | PubTator, text mining | PubMed |
| Calciprotein Particles Induce Cellular Compartment-Specific Proteome Alterations in Human Arterial Endothelial Cells. | J Cardiovasc Dev Dis | 2023 | 38248875 | PubTator, text mining | PubMed |
| The Regulation of Exosome Generation and Function in Physiological and Pathological Processes. | Int J Mol Sci | 2023 | 38203424 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Advances in the regulatory mechanisms of mTOR in necroptosis. | Front Immunol | 2023 | 38164133 | PubTator, text mining | PubMed |
| ATP-induced cell death: a novel hypothesis for osteoporosis. | Front Cell Dev Biol | 2023 | 38161333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=4